| Authors: |
Han Y; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Zhou Q; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Dibbs A; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Chen B; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Weiskittel TM; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota; Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, Minnesota., Remmes NB; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Wu Z; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Ebner DK; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Kloeber JA; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Callaghan CM; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Bendel AE; Children's Hospitals and Clinics of Minnesota, Minneapolis, Minnesota., Mullikin TC; Department of Radiation Oncology, Duke University, Durham, North Carolina., Laack NN; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Xu-Welliver M; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Lou Z; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota; Department of Oncology, Mayo Clinic, Rochester, Minnesota. Electronic address: Lou.Zhenkun@mayo.edu., Mutter RW; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota. Electronic address: Mutter.Robert@mayo.edu. |
